Please provide your email address to receive an email when new articles are posted on . Total body irradiation plus etoposide improved OS and appeared to reduce risk for relapse among children with ...

FORUM is a randomized, controlled, open-label, international, multicenter, phase III, noninferiority study. Patients ≤ 18 years at diagnosis, 4-21 years at HSCT, in complete remission pre-HSCT, and ...

The EndRAD study showed non-TBI conditioning in B-ALL patients achieved comparable EFS and OS rates to TBI-based regimens. The trial's primary endpoint was met with a two-year EFS rate of 76.3% and an ...

The aim of this current study was to quantitatively describe radiation-induced DNA damage and its distribution in leukocytes of cancer patients after fractionated partial- or total-body radiotherapy.

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials We performed an open-label, randomized ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

Radiation therapy in the form of total body irradiation (TBI) technique continues to be an important part of conditioning regimens in patients undergoing bone-marrow transplantation in haematological ...